Insider Transactions in Q2 2025 at Insmed Inc (INSM)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 14
2025
|
Sara Bonstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,634
-1.49%
|
$106,210
$65.61 P/Share
|
|
May 14
2025
|
Melvin Md Sharoky Director |
BUY
Bona fide gift
|
Indirect |
576
+50.0%
|
-
|
|
May 14
2025
|
Melvin Md Sharoky Director |
SELL
Bona fide gift
|
Direct |
576
-0.19%
|
-
|
|
May 13
2025
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
4,999
-4.14%
|
$334,933
$67.81 P/Share
|
|
May 13
2025
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
4,407
-4.56%
|
$295,269
$67.81 P/Share
|
|
May 13
2025
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
8,408
-8.39%
|
$563,336
$67.81 P/Share
|
|
May 13
2025
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
17,442
-2.64%
|
$1,168,614
$67.05 P/Share
|
|
May 13
2025
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
7,482
-5.12%
|
$501,294
$67.81 P/Share
|
|
May 13
2025
|
Sara Bonstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,870
-7.46%
|
$594,290
$67.81 P/Share
|
|
May 01
2025
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Indirect |
6,830
-1.43%
|
$491,760
$72.51 P/Share
|
|
May 01
2025
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
6,830
+2.76%
|
$68,300
$10.85 P/Share
|
|
Apr 15
2025
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Indirect |
6,830
-0.95%
|
$478,100
$70.49 P/Share
|
|
Apr 15
2025
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
6,830
+2.76%
|
$68,300
$10.85 P/Share
|
|
Apr 01
2025
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Indirect |
6,830
-0.72%
|
$498,590
$73.94 P/Share
|
|
Apr 01
2025
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
6,830
+2.76%
|
$68,300
$10.85 P/Share
|